Melinta Therapeutics (NASDAQ:MLNT) prices its public offering of 22M shares of common stock at $5.00 per share. The size of the offering was upsized from $75M to $110M. Underwriters over-allotment is an additional 2.64M shares.
Closing date is May 29.
Shares are down 12% premarket.
Previously: Melinta Therapeutics down 10% on announcing public offering of common stock (May 22)
Update: On May 29, the company announced that it raised $123.2M in the offering including the full exercise of the underwriters' over-allotment.
Subscribe for full text news in your inbox